Dermatology News CME/CE

• Patients With IBD at Risk of Developing Nonmelanoma Skin Cancer CME Immunosuppressant therapy for inflammatory bowel disease (IBD) is associated with an increased risk for nonmelanoma skin cancer.
  Medscape Medical News CME, October 2009
• Herpes Zoster Attacks Increase Stroke Risk By 30% CME A new epidemiologic study shows that the risk for stroke increases after a zoster attack (shingles) by 30% and by up to 4-fold when the attack involves the eye.
  Medscape Medical News CME, October 2009
• FDA Approvals: Tamiflu, Stelara, Folotyn CME/CE The FDA has approved use of oseltamivir phosphate 12-mg/mL oral suspension, ustekinumab subcutaneous injection, and accelerated approval and orphan drug status for pralatrexate injection.
  Medscape Medical News CME, October 2009
• FDA Approvals: H1N1 Vaccine, Ova1, Vibativ CME/CE The FDA has approved 4 vaccines against the 2009 H1N1 virus, a blood test to detect ovarian cancer, and telavancin to treat MRSA skin infections.
  Medscape Medical News CME, September 2009
• Treatment of Acne Rosacea Reviewed CME/CE Topical metronidazole, sulfacetamide/sulfur, and azelaic acid are generally effective for mild rosacea; combination therapy is the first-line choice for moderate papulopustular rosacea.
  Medscape Medical News CME, September 2009
• Dermoscopic Criteria, Patient Factors May Help Manage Pigmented Melanocytic Nevi CME Dermoscopy is a useful technique for diagnosing melanocytic nevi, along with patient-related factors, and the 4 x 4 x 6 "rule" may help clinicians evaluate pigmented lesions.
  Medscape Medical News CME, September 2009
• Primary Care Management of Keloids and Hypertrophic Scars Reviewed CME Keloids and hypertrophic scars result from an exuberant healing response and are often difficult to distinguish and treat.
  Medscape Medical News CME, August 2009
• Antioxidants Not Associated With Increased Risk for Melanoma CME Results of a large prospective study suggest that there is no association between melanoma risk and the supplemental use of multivitamins, selenium, and beta carotene.
  Medscape Medical News CME, August 2009
• Superficial Vein Thrombosis Linked to Deep Vein Thrombosis CME A prospective study shows that approximately one fourth of patients with superficial vein thrombosis affecting the skin may have also deep vein thrombosis, a potentially life-threatening condition.
  Medscape Medical News CME, August 2009
• FDA Safety Changes: Aristospan, Videx/Videx EC, Coreg/Coreg ER CME/CE The FDA has approved safety labeling revisions for triamcinolone hexacetonide, didanosine oral solution and delayed-release capsules, carvedilol tablets, and carvedilol extended-release tablets.
  Medscape Medical News CME, July 2009
• FDA Safety Changes: Prevpac, Arava, Treanda CME/CE The FDA has approved safety labeling revisions for a prepackaged regimen of lansoprazole, amoxicillin, and clarithromycin tablets; leflunomide tablets; and bendamustine HCl intravenous infusion.
  Medscape Medical News CME, July 2009
• Psoriasis Associated With All Vascular Disease CME As well as being an independent risk factor for cardiovascular disease, psoriasis is also associated with an increased risk of cerebrovascular disease and peripheral arterial disease, a new case-control study has shown.
  Heartwire CME, June 2009
• Hydroxychloroquine Use May Be Safe in Systemic Lupus Erythematosus CME A systematic review suggests that hydroxychloroquine should be given to most patients with systemic lupus erythematosus during the whole course of the disease and should be continued during pregnancy.
  Medscape Medical News CME, June 2009
• Home Phototherapy Is as Safe, Effective as Outpatient Therapy for Treating Psoriasis CME In a randomized controlled trial, ultraviolet B phototherapy given at home or in an outpatient setting were equally safe and effective in the treatment of psoriasis, both clinically and for quality of life.
  Medscape Medical News, May 2009
• FDA Safety Changes: Visicol, OsmoPrep, DiaBeta, Raptiva CME/CE The FDA has approved safety labeling revisions for sodium phosphate monobasic monohydrate and sodium phosphate dibasic anhydrous tablets (Visicol and OsmoPrep), glyburide tablets (DiaBeta), and efalizumab subcutaneous injection (Raptiva).
  Medscape Medical News, May 2009
• Factors Identified Linked to Early Detection of Melanoma in Older Men CME Physician-detected melanoma in older men is more likely to be thinner, more treatable, located on the back, and associated with a history of atypical nevi.
  Medscape Medical News, April 2009
• Psoriasis Linked to Increased Risk for Diabetes and Hypertension CME/CE In a prospective study of US female nurses, psoriasis was independently associated with an increased risk for diabetes and hypertension.
  Medscape Medical News, April 2009
• FDA Approvals: Coartem and Benzyl Alcohol Lotion CME/CE The FDA has approved artemether-lumefantrine tablets (Coartem) and benzyl alcohol 5% lotion.
  Medscape Medical News, April 2009
• FDA Safety Changes: Tracleer, Nexium, Nexium IV, Tygacil CME/CE The FDA has approved revisions to the safety labeling for bosentan tablets, esomeprazole injection, esomeprazole magnesium delayed-release capsules and oral suspension, and tigecycline injection.
  Medscape Medical News, April 2009
• Combing Wet Hair May Be Best to Identify Active Head Lice Infestation CME A study shows that combing through a child's wet hair may be more accurate than visual inspection to identify active head lice infestation.
  Medscape Medical News, March 2009